Search results
Results from the WOW.Com Content Network
Iron obtained from iron preparation is eliminated from the body in a similar manner as dietary iron. Iron is mostly conserved and recycled in the body with minimal loss. [ 18 ] A very limited loss is estimated to be approximately 1 mg/day, [ 19 ] mainly by sweating and epithelial cell exfoliation on the skin, genitourinary tract , and ...
In 1992 it was removed from the market and manufacturing ceased. During this time low molecular weight iron dextran was introduced and released for clinical use in 1992. [4] The use of low molecule weight iron dextran was common place for renal dialysis patients and due to its success usage increased progressively through to 1997. [4]
Iron can be supplemented by mouth using various forms, such as iron(II) sulfate. This is the most common and well studied soluble iron salt sold under brand names such as Feratab, Fer-Iron, and Slow-FE. It is in complex with gluconate, dextran, carbonyl iron, and other salts.
For premium support please call: 800-290-4726 more ways to reach us
It replaced iron dextran, which had been in use in the US since the 1900s, as a treatment for iron deficiency. Iron dextran was only used for extremely high risk situations, because it released enough iron at once to be toxic to the body. Further development of iron dextran was able to lower these reactions, but also caused more severe ...
Dextran and oxidized dextran can be used to crosslink gelatin microspheres to reduce gelatin dissolution, which slows the drug release rate. These dextran/gelatin microspheres can be used to provide slow-release of TRAPP-Br, which is a cancer therapeutic. [ 8 ]
President-elect Donald Trump's chief of staff Susie Wiles sent a message Sunday ordering nominees to refrain from any posting on social media as Senate confirmation hearings are scheduled to start ...
Dextran-Haemoglobin was developed by Dextro-Sang Corp as a veterinary product, and was a conjugate of the polymer dextran with human haemoglobin. [citation needed] Hemotech was developed by HemoBiotech and was a chemically modified haemoglobin. Somatogen developed a genetically engineered and crosslinked tetramer it called Optro.